Therapies based on GLP-1 receptor agonists: significance, challenges, and opportunities. - Jackson-Morris A; Halpern B; Segafredo G; Baur L; Sealey K; Kushner RF; Sperling L; Mutungi H; Schwarz P; Buse K; Ralston J (The Lancet. Global health, 2026)